Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
85.6M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
14.4M
-
Shares change
-
-835K
-
Total reported value, excl. options
-
$28.2M
-
Value change
-
-$2.24M
-
Number of buys
-
4
-
Number of sells
-
-16
-
Price
-
$1.96
Significant Holders of Larimar Therapeutics, Inc. - Common Stock (LRMR) as of Q2 2022
40 filings reported holding LRMR - Larimar Therapeutics, Inc. - Common Stock as of Q2 2022.
Larimar Therapeutics, Inc. - Common Stock (LRMR) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.4M shares
of 85.6M outstanding shares and own 16.81% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5.83M shares), CHI Advisors LLC (1.52M shares), RA CAPITAL MANAGEMENT, L.P. (1.03M shares), Opaleye Management Inc. (933K shares), MANGROVE PARTNERS (868K shares), JANUS HENDERSON GROUP PLC (749K shares), MORGAN STANLEY (530K shares), VANGUARD GROUP INC (511K shares), Verition Fund Management LLC (404K shares), and Atlas Venture Advisors, Inc. (292K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.